zidovudine has been researched along with diba-1 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aberham, C; Burke, TR; De Clercq, E; Debyser, Z; Kiryu, Y; Kohn, K; Lin, Z; Neamati, N; Pannecouque, C; Pommier, Y; Rice, WG; Strebel, K; Turpin, JA; Witvrouw, M; Zhao, H | 1 |
Bagnoli, L; Desantis, J; Iraci, N; Marini, F; Mariotti, A; Pannecouque, C; Sancineto, L; Santi, C; Tabarrini, O | 1 |
2 other study(ies) available for zidovudine and diba-1
Article | Year |
---|---|
Chicoric acid analogues as HIV-1 integrase inhibitors.
Topics: Animals; Anti-HIV Agents; Caffeic Acids; Cell Line; Drug Evaluation, Preclinical; HIV Integrase; HIV Integrase Inhibitors; HIV-1; HIV-2; Humans; Stereoisomerism; Structure-Activity Relationship; Succinates; Virus Replication | 1999 |
Design and Synthesis of DiselenoBisBenzamides (DISeBAs) as Nucleocapsid Protein 7 (NCp7) Inhibitors with anti-HIV Activity.
Topics: Anti-HIV Agents; Benzamides; Cell Line, Tumor; Drug Resistance, Viral; gag Gene Products, Human Immunodeficiency Virus; Glutamic Acid; Glycine; HIV-1; Humans; Isoleucine; Molecular Docking Simulation; Molecular Dynamics Simulation; Organoselenium Compounds; Simian Immunodeficiency Virus; Structure-Activity Relationship | 2015 |